Effect of polycystic ovary syndrome on increased risk of cardiovascular disease
Open Access
- 19 August 2023
- journal article
- research article
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 45 (1) , 284-298
Abstract
Introduction and purpose: Polycystic ovary syndrome (PCOS) is one of the most common endocrine disorders in women. It is a very complex disease in which hormonal disorders result in a number of metabolic dysfunctions and malfunctioning of the ovaries. This can lead to infertility, miscarriage and an increased risk of endometrial cancer. The aim of our work is to draw attention to the influence of PCOS on increased cardiovascular risk. Brief description of the state of knowledge: The occurrence of PCOS, especially uncontrolled pharmacologically and non-pharmacologically, may be associated with an increased cardiovascular risk. The literature describes a higher incidence of dyslipidemia, carbohydrate metabolism disorders, obesity, hypertension, chronic inflammation and oxidative stress. As a consequence, it can lead to the development of metabolic syndrome. All these factors negatively affect the risk of developing cardiovascular disease. To prevent this, it is necessary to use appropriate pharmacological and non-pharmacological methods in women diagnosed with PCOS. Conclusion: The mechanism of PCOS is complex and its development is influenced by genetic, endocrine, metabolic and environmental factors. The lack of proper diagnosis and the lack of treatment of PCOS is associated with numerous metabolic complications and an increased risk of cardiovascular diseases. Due to the poorly understood pathomechanism of this disease, further long-term studies are needed to help diagnose and treat PCOS.Keywords
This publication has 37 references indexed in Scilit:
- Polycystic ovarian syndrome (PCOS): Long-term metabolic consequencesMetabolism, 2018
- Polycystic ovary syndromeNature Reviews Disease Primers, 2016
- Criteria, prevalence, and phenotypes of polycystic ovary syndromeFertility and Sterility, 2016
- The CardioMetabolic Health AllianceJACC, 2015
- Vascular wall extracellular matrix proteins and vascular diseasesBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2014
- Metabolic and other effects of pioglitazone as an add-on therapy to metformin in the treatment of polycystic ovary syndrome (PCOS)Hormones, 2013
- Lipid levels in polycystic ovary syndrome: systematic review and meta-analysisFertility and Sterility, 2011
- Circulating inflammatory markers in polycystic ovary syndrome: a systematic review and metaanalysisFertility and Sterility, 2011
- Indices of insulin sensitivity, beta cell function and serum proinsulin levels in the polycystic ovary syndromeEuropean Journal of Obstetrics & Gynecology and Reproductive Biology, 2006
- Effect of Weight Loss and Lifestyle Changes on Vascular Inflammatory Markers in Obese WomenJAMA, 2003